Financial Statements · Financial Reporting

Narafarm OÜ

Official identifier 12139312Record date 31 Dec 2021
Estonia

Report

Legal form
OÜ
Report status
Registered

Dates

Reporting year
2021
Period start
1 Jan 2021
Submitted date
30 Jun 2022

Report

Consolidated
No
Audited
No

Financial metrics

StatementMetricValue
Bilanss, detailneAssets906,942
Bilanss, detailneCash and cash equivalents86,133
Bilanss, detailneCurrent assets190,332
Bilanss, detailneCurrent liabilities118,267
Bilanss, detailneEquity515,691
Bilanss, detailneShare capital at nominal value2,500
Bilanss, detailneNon-current assets716,610
Bilanss, detailneNon-current liabilities272,984
Bilanss, detailneRetained earnings (loss) from previous periods368,476
Income statement scheme 1Depreciation and impairment of non-current assets-59,709
Income statement scheme 1Labour costs-19,612
Income statement scheme 1Revenue274,345
Income statement scheme 1Annual period profit / loss144,465
Income statement scheme 1Operating profit (loss)148,660
Income statement scheme 1Profit (loss) before income tax144,465
Profit distribution proposalRetained earnings (loss) from previous periods368,476
Note: Labour costsEmployees2
Note: Labour costsLabour costs19,612

Linked company

Company: Narafarm OÜ

Source

Estonian e-Business Register Annual Reports open data

View published source

Back to Financial Statements